Sacituzumab Govitecan

ATC L01FX17 · 10 markets · 13 records

Sacituzumab Govitecan 10 markets · 13 records Forms

AU 3 records · 2 strengths

180 mginjectionTRODELVY+1TRODELVY sacituzumab govitecan 180 mg powder for injection vial also in GB unknown

Records without a stated strength · 1 TRODELVY

ES 2 records · 1 strengths

200 mginjectionTRODELVY

US 1 records · 1 strengths

180 mgpowderTRODELVY also in CA

GB 1 records · 1 strengths

180 mginjectionTrodelvy 180mg powder for concentrate for solution for infusion vials also in AU

CA 1 records · 1 strengths

180 mgpowderTRODELVY also in US

SG 1 records · 1 strengths

180 mg/vialinjectionTRODELVY POWDER FOR SOLUTION FOR INFUSION 180 MG/VIAL

MX 1 records · 1 strengths

Records without a stated strength · 1 TRODELVY

TW 1 records · 1 strengths

Records without a stated strength · 1 TRODELVY for Injection、拓達維注射劑

HK 1 records · 1 strengths

Records without a stated strength · 1 TRODELVY POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 180MG

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 TRODELVY

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	MX	TW	HK	EU
180 mg injection	not recorded	Trodelvy 180mg powder for concentrate for solution for infusion vials	not recorded	TRODELVY TRODELVY sacituzumab govitecan 180 mg powder for injection vial	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
180 mg powder	TRODELVY	not recorded	TRODELVY	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
200 mg injection	not recorded	not recorded	not recorded	not recorded	not recorded	TRODELVY	not recorded	not recorded	not recorded	not recorded
180 mg/vial injection	not recorded	not recorded	not recorded	not recorded	TRODELVY POWDER FOR SOLUTION FOR INFUSION 180 MG/VIAL	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	TRODELVY	not recorded	not recorded	not recorded	not recorded	TRODELVY POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 180MG	TRODELVY
not disclosed injection	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	TRODELVY for 拓達維注射劑	not recorded	not recorded
not disclosed liquid	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	TRODELVY	not recorded	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

3 more strength/form rows are recorded only in SG · ES · MX and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en SG · ES · MX que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 SG · ES · MX 有记录（未在本表显示）。另有 3 個規格/劑型僅在 SG · ES · MX 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.